Avidity Biosciences Inc
RNA
Get informed when a big investor buys or sells
+ FollowMarket Cap$225.79M
Close$
$-10.92
178.8% downside
Current Fair Value
178.8% downsideOvervalued by 178.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $225.79 Million |
|---|---|
| Enterprise Value | $163.87 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.48 |
| Beta | 0.37 |
| Outstanding Shares | 17,106,000 |
Return
| Return on Equity | -208.95% |
|---|---|
| Return on Assets | -159.84% |
| Return on Invested Capital | -181.30% |
Valuation & Multiples
| P/E Ratio | -3.43 |
|---|---|
| PEG | 3.93 |
| Price to Sales | 6.93 |
| Price to Book Ratio | 1.15 |
| Enterprise Value to Revenue | 4.56 |
| Enterprise Value to EBIT | -0.36 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-1.42
Average shareholder expectationRevenue Estimate
$666,667
Average shareholder expectationNext Earnings Call
Expected Date
September 2, 2026
EPS Estimate
$-1.16
Average shareholder expectationRevenue Estimate
$666,667
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 13.0927▼ 419.48% |
|---|---|
| Total Calls | 65,800▼ 0.30% |
| Total Puts | 861,500▼ 24.49% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 84.14%▼ 2.68% |
|---|---|
| Total Invested | $193.72M▼ 2.44% |
| Investors Holding | 158▼ 9.00% |
ESG Score
No data